All the Drug Class Drugs
Interlukin-1 Receptor Inhibitor. Anakinra 150 mg/ml. PREFILL. SYR (sol.for inject.): 1, 28. 1 x dly,
S.C. inject. in pts. > 18 yrs.
treatment of the signs and symptoms of
rheumatoid arthritis in combination with
Methotrexate, in patients with an
inadequate response to Methotrexate
alone. adults, adolescents, children and
infants aged 8 months and older with a
body weight of 10 kg or above for the
treatment of Cryopyrin-Associated
Periodic Syndromes (CAPS), including:
Neonatal-Onset Multisystem
Inflammatory Disease (NOMID) /Chronic
Infantile Neurological, Cutaneous,
Articular Syndrome (CINCA)Muckle-Wells
Syndrome (MWS). Familial Cold
Autoinflammatory Syndrome (FCAS).
C/I: Hypersensitivity to the active
substance or to any of the excipients or
to E. coli derived proteins. Kineret must
not be used in patients with severe renal
impairment (CLcr < 30 ml/minute)
Kineret treatment must not be initiated
in patients with neutropenia (ANC <1.5 x
10^9/l).
